Pharmacy Supply Chain Visibility Crisis Threatens Healthcare Resilience
Event summary
- A Tecsys survey found that only 20% of US healthcare leaders have real-time visibility across pharmacy inventory and care settings.
- 77% of healthcare leaders report being unprepared for major disruptions, with drug shortages cited as the primary cause (79%).
- Data readiness is hindering AI adoption in pharmacy, with only 15% fully deploying AI/ML for key functions.
- There's a misalignment between pharmacy/supply chain leaders (48%) and hospital executives (15%) regarding the strategic value of pharmacy operations.
The big picture
The survey highlights a systemic vulnerability within US healthcare, where a lack of supply chain visibility is exacerbating the impact of drug shortages and operational pressures. This crisis represents a significant opportunity for technology providers like Tecsys, but also underscores the broader need for healthcare organizations to prioritize digital transformation and data-driven decision-making to ensure patient care continuity. The misalignment in strategic perception suggests a deeper cultural shift is needed within healthcare to value and invest in supply chain resilience.
What we're watching
- Adoption Hurdles
- The slow pace of AI/ML adoption suggests data integration challenges and potential resistance to change within healthcare organizations, which could limit the impact of Tecsys' solutions.
- Strategic Alignment
- The disconnect between pharmacy leaders' perception of their strategic value and hospital executives' view indicates a need for better communication and demonstration of ROI to elevate pharmacy's role within health systems.
- Regulatory Impact
- Increased regulatory scrutiny of drug supply chains, particularly in the wake of persistent shortages, will likely accelerate the demand for real-time visibility solutions and put pressure on healthcare providers to modernize their operations.
Related topics